Octamoxin
From Wikipedia, the free encyclopedia
| Names | |
|---|---|
| Preferred IUPAC name
1-Methylheptylhydrazine[citation needed] | |
| Systematic IUPAC name
Octan-2-ylhydrazine[1] | |
| Identifiers | |
3D model (JSmol)
|
|
| ChemSpider |
|
PubChem CID
|
|
| UNII | |
CompTox Dashboard (EPA)
|
|
| |
| |
| Properties | |
| C8H20N2 | |
| Molar mass | 144.262 g*mol-1 |
| Density | 0.831 g/mL |
| Boiling point | 228 degC (442 degF; 501 K) |
| Pharmacology | |
| Oral | |
| Related compounds | |
Related compounds
|
Tuaminoheptane |
Except where otherwise noted, data are given for materials in their standard state (at 25 degC [77 degF], 100 kPa).
| |
Chemical compound
Octamoxin (trade names Ximaol, Nimaol), also known as 2-octylhydrazine, is an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine class that was used as an antidepressant in the 1960s but is now no longer marketed.[2][3][4][5]
See also
[edit]References
[edit]- ^ "Octamoxin - Compound Summary". USA: National Center for Biotechnology Information. 26 March 2005. Identification and Related Records. Retrieved 31 May 2012.
- ^ Ganellin CR, Triggle DJ (21 November 1996). Dictionary of pharmacological agents - Google Books. CRC Press. ISBN 9780412466304.
- ^ "13-06781. Octamoxin [Archived]: The Merck Index".
- ^ Levy J, Michel-Ber E (1966). "[Relations between the antidepressive effects of octamoxine revealed by 3 pharmacological tests and inhibition of cerebral monoamine oxidase in mice]". Therapie (in French). 21 (4): 929-45. PMID 5925088.
- ^ Gayral L, Stern H, Puyuelo R (1966). "[Indications and results of the treatment of mental depression by octamoxine (ximaol)]". Therapie (in French). 21 (5): 1183-90. PMID 5976767.
This drug article relating to the nervous system is a stub. You can help Wikipedia by adding missing information. |
